While the majority of clinical evidence pointed to a tumor‐promoting role of ERα (Albain et al., 1991; Ganti et al., 2006; Kawai et al., 2005), ERα was also reported to have a protecting effect for cancer progression (Brueckl et al., 2013). This evidence concerns the gene ESR1 and cancer.